SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.85p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 9.85
  • 52 Week Low: 9.85
  • Currency: UK Pounds
  • Shares Issued: 259.04m
  • Volume: 0
  • Market Cap: £25.52m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Martin Braddock Hunt 466,667 £45,967
Stuart Ashman 455,060 £44,823
Catherine Denise Prescott 118,612 £11,683

Major Shareholders

Notifier** Holding Value*
Mark H Dixon and Diana Dixon 69,900,000 £6,885,150
Mark H Dixon 50,000,000 £4,925,000
David Campbell Brierwood 16,416,813 £1,617,056
Tyndall Investment Management 13,165,553 £1,296,807
Tyndall Investment Management 13,165,553 £1,296,807
Seneca Partners Limited 10,561,405 £1,040,298
Unicorn Asset Management Limited 7,894,736 £777,632
Andrew McBain 4,301,433 £423,691

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.85p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 9.85
52 Week Low 9.85
Volume 0
Shares Issued 259.04m
Market Cap £25.52m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page